Teleflex Incorporated

Equities

TFX

US8793691069

Medical Equipment, Supplies & Distribution

Delayed Nyse 04:00:02 2024-03-28 pm EDT 5-day change 1st Jan Change
226.2 USD +1.03% Intraday chart for Teleflex Incorporated +0.79% -9.29%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Teleflex Gets Science Based Targets Initiative Validation For Climate Targets MT
Teleflex Insider Sold Shares Worth $1,713,825, According to a Recent SEC Filing MT
Teleflex to Seek M&A CI
Transcript : Teleflex Incorporated Presents at 45th Annual Raymond James Institutional Investors Conference 2024, Mar-05-2024 01:40 PM
Truist Securities Trims Price Target on Teleflex to $265 From $270, Maintains Hold Rating MT
RBC Cuts Price Target on Teleflex to $265 From $272, Keeps Outperform Rating MT
Teleflex to Seek M&A CI
Transcript : Teleflex Incorporated, Q4 2023 Earnings Call, Feb 22, 2024
Teleflex's Q4 Adjusted Earnings Fall, Revenue Rises; 2024 Guidance Issued MT
Teleflex Incorporated Announces Quarterly Dividend, Payable on March 15, 2024 CI
Earnings Flash (TFX) TELEFLEX INCORPORATED Posts Q4 Revenue $773.9M MT
Earnings Flash (TFX) TELEFLEX INCORPORATED Posts Q4 EPS $3.38 MT
Teleflex Incorporated Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Teleflex Incorporated Provides Earnings Guidance for the Year 2024 CI
MORNING BID AMERICAS-AI 'tipping point' sends Nvidia, Nasdaq, Nikkei north RE
Trump is back (and so is Wall Street) Our Logo
ANALYST RECOMMENDATIONS : AMD, Cloudflare, Intel, ITV, PayPal... Our Logo
RBC Boosts Price Target on Teleflex to $272 From $228 on Recent Stock Rise, Peer Multiples, 'Durable Growth Story'; Outperform Kept MT
Transcript : Teleflex Incorporated Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 03:00 PM
Teleflex Incorporated Offers Its Titan SGS Stapler with Staple Line Reinforcement CI
Truist Securities Hikes Price Target on Teleflex to $270 From $221, Maintains Hold Rating MT
Raymond James Adjusts Price Target on Teleflex to $271 From $227, Keeps Outperform Rating MT
Teleflex Incorporated Wins Peripheral Access Agreement with Premier, Inc CI
North American Morning Briefing : China Outlook -2- DJ
Let's party like it's 2021 Our Logo
Chart Teleflex Incorporated
More charts
Teleflex Incorporated specialises in the designing, manufacturing and selling of single-use medical devices for hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. Products are sold under the brand names Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch® and Weck®. Net sales break down by category of products as follows: - interventional cardiology, radiology and urology products (26.5%); - vascular access solutions (25.9%); - surgical devices (12.5%); - anesthesia products (11.9%); - other (23.2%). Net sales are distributed geographically as follows: the United States (61.8%), Europe (25.5%), Asia-Pacific (9.1%) and other (3.6%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
226.2 USD
Average target price
264.3 USD
Spread / Average Target
+16.88%
Consensus
  1. Stock
  2. Equities
  3. Stock Teleflex Incorporated - Nyse
  4. News Teleflex Incorporated
  5. Teleflex Incorporated : KeyBanc Adjusts Price Target on Teleflex to $441 From $382, Reiterates Overweight Rating